Skip to content
Financing

Payments For Proceeds From Derivative Instrument Financing Activities

MetLife Payments For Proceeds From Derivative Instrument Financing Activities decreased by 38.3% to $71M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $71M to $71M.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2014
Last reportedQ1 2026May 7, 2026
Metric ID: financing_payments_for_proceeds_from_derivative_instrume_ad5f23

Historical Data

14 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q3 '23Q1 '24Q2 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$105M-$16M$121M$61M-$60M$228M$55M$95M$116M$71M$3M$58M$115M$71M
QoQ Change+84.8%+856.3%-49.6%-198.4%+480.0%-75.9%+72.7%+22.1%-38.8%-95.8%>999%+98.3%-38.3%
YoY Change+42.9%+88.4%+191.7%+29.1%-96.8%-0.9%+0.0%
Range-$105M$228M
CAGR-11.3%
Avg YoY Growth+36.3%
Median YoY Growth+29.1%

Frequently Asked Questions

What is MetLife's payments for proceeds from derivative instrument financing activities?
MetLife (MET) reported payments for proceeds from derivative instrument financing activities of $71M in Q1 2026.
How has MetLife's payments for proceeds from derivative instrument financing activities changed year-over-year?
MetLife's payments for proceeds from derivative instrument financing activities decreased by 0.0% year-over-year, from $71M to $71M.